Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01464840 · ClinicalTrials.gov registry record
The Pharmacokinetics of Azithromycin Prophylaxis for Cesarean Delivery
A clinical trial, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 30
- Enrollment target
NCT01464840: Completed study, sponsored by University of Alabama at Birmingham.
NCT01464840 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01464840 has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
PKAZ is a single institution study designed to evaluate the optimal dosing parameters for azithromycin for pre-surgical cesarean prophylaxis. Hypothesis: Pre-operative administration of azithromycin results in maternal and neonatal tissue concentrations that adequately treat microbes commonly involved in post-cesarean infections.
Primary Outcome
The primary outcome of this study will be the number of patients in each group that attain an azithromycin concentration in the various maternal and fetal tissues at least equivalent to the MIC 90 for common organisms involved in post-cesarean infections.
Interventions
- DRUG Azithromycin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2011-11 |
| Est. Completion | 2013-08 |
What the finished NCT01464840 record still lists
NCT01464840 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Azithromycin is the first listed.
NCT01464840 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01464840 about?
NCT01464840 is a clinical study titled "The Pharmacokinetics of Azithromycin Prophylaxis for Cesarean Delivery". PKAZ is a single institution study designed to evaluate the optimal dosing parameters for azithromycin for pre-surgical cesarean prophylaxis. Hypothesis: Pre-operative administration of azithromycin results in maternal and neonatal tissue concentrations that adequately treat microbes commonly invol...
What is the current status of trial NCT01464840?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2011-11. Estimated completion is 2013-08.
What interventions are being tested in trial NCT01464840?
The interventions under investigation include: Azithromycin (DRUG).
Who is sponsoring clinical trial NCT01464840?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia